Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up.

6533b86cfe1ef96bd12c81bf

RESEARCH PRODUCT

Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up.

Tn Nguyen Mm Qureshi P Klein H Yamagami R Mikulik N Etminan M Abdalkader Oy Mansour A Czlonkowska H Lo A Sathya J Demeestere G Tsivgoulis N Sakai P Sedova Es Kristoffersen M Mohammaden Vp Lereis Sd Scollo A Ma A Rahman T Bonnet J Cortier S De Raedt R Lemmens N Ligot Rct Hidalgo Dlm Cuervo Ld Neves Mts Rezende Ib Santiago A Sirakov S Sirakov Ea Cora Me Kelly P Lavoie L Peeling A Pikula R Rivera Hs Chen Ym Chen Hl Fang Mr Bedekovic H Budincevic Jj Strossmayer E Hrabanovska L Jurak M Cabal J Kadlckova I Karpowicz H Palouskova M Reiser L Klecka M Kovar J Neumann P Rekova M Sramek E Vitkova M Skorna L Zakova K Sobh K Alpay R Rautio D Strbian Jc Gentric E Magro O Naggara P Reiner A Abdulazim Fo Bohmann S Boskamp Jc Gerber Dpo Kaiser Ri Kestner J Mbroh M Neyazi M Rosenkranz Af Sani S Poli G Thomalla T Karapanayiotides O Kargiotis I Koutroulou L Palaiodimou Jdb Guerra V Huded S Nagendra C Prajapati A Krishna A Ghoreishi Rb Ilkhchi J Jalili Si Sabetay T Abu Raya M Acampa M Longoni Cr Bigliani L Castellan R Ornello L Renieri M Romoli S Sacco D Sangalli M Vigano A Zini H Tokimura K Sonoda K Todo H Fukuda K Fujita M Sakaguchi M Uno I Kan M Kosuke R Kono N Kimura N Yamamoto R Yamamoto R Doijiri S Shindo N Ohara H Imamura T Ogawa T Uwatoko T Kanamaru T Fujinaka Y Takenobu K Toyoda Y Matsumaru Y Yazawa Y Sugiura Jh Baek Ta Sunmonu Ys Kwon Yh Lee Kd Seo Si Sohn Yc Chan Waw Zaidi J Barrientos-prieto F Gongora-rivera M Martinez-marino A Calderon-vallejo S Groppa L Pavel Jm Coutinho D Dippel L Rinkel Dhk Van Dam-nolen Eo Nwazor Am Al Hashimi S Ahmad U Rashid L Rodriguez-kadota Ma Vences Pm Yalung Dy Jsh W Brola M Dorobek Ma Karlinski Bm Labuz-roszak A Lasek-bal H Sienkiewicz-jarosz J Staszewski P Sobolewski J Zielinska-turek Ap Araujo L Fonseca A Debiec Ml Silva P Castro M Rocha Rc Falup-pecurariu N Venketasubramanian Gkm Mako O Ayo-martin M Wiacek J Blasco A Cruz-culebras F Hernandez-fernandez Cr Fernandez Je Lopez A Rodriguez M Bolognese Gm Karwacki E Keller P Machi G Bernava S Boonyakarnkul A Churojana N Hammami A Bajrami S Senadim Si Hussain S John G Dow K Krishnan R Lenthall K Wong Lq Zhang D Altschul Ks Asif Ma Aziz-sultan I Bach K Below J Biller Am Cervantes-arslanian Sa Chaudhry A Chebl M Chen M Colasurdo A Czap H Dasenbrock Z Bahiru Ah De Havenon S Dharmadhikari Aa Dmytriw Cj Eskey M Etherton C Ezepue L Fink U Gasimova N Goyal Kb Grimmett M Hakemi T Hester V Inoa Pt Kan Em Kasper P Khandelwal R Khatri Nn Khoury Bs Kim M Kolikonda Al Kuhn G Linares I Linfante Ai Loochtan Tg Lukovits Ss Male Am Khawaja L Maali Em Galecio-castillo Jy Min Ga Mohamed K Nalleballe S Ortega-gutierrez Y Radaideh P Ramakrishnan He Masoud Ab Reddy S Ruland Ss Omran Sa Sheth As Puri Rh Rahangdale Je Siegler Ak Starosciak Ne Tarlov Ra Taylor J Tsai Mj Wang Kh Wong Oo Zaidat Le Hv Ht Phan Md Ton Ad Tran K Sirakova Tn Pham Ma Mohlenbruch S Nagel J Raymond Rg Nogueira

subject

Psychiatry and Mental health SDG 3 - Good Health and Well-being COVID-19 SUBARACHNOID HAEMORRHAGE CEREBROVASCULAR DISEASE; COVID-19; SUBARACHNOID HAEMORRHAGE Surgery CEREBROVASCULAR DISEASE Neurology (clinical)

description

BackgroundPrior studies indicated a decrease in the incidences of aneurysmal subarachnoid haemorrhage (aSAH) during the early stages of the COVID-19 pandemic. We evaluated differences in the incidence, severity of aSAH presentation, and ruptured aneurysm treatment modality during the first year of the COVID-19 pandemic compared with the preceding year.MethodsWe conducted a cross-sectional study including 49 countries and 187 centres. We recorded volumes for COVID-19 hospitalisations, aSAH hospitalisations, Hunt-Hess grade, coiling, clipping and aSAH in-hospital mortality. Diagnoses were identified by International Classification of Diseases, 10th Revision, codes or stroke databases from January 2019 to May 2021.ResultsOver the study period, there were 16 247 aSAH admissions, 344 491 COVID-19 admissions, 8300 ruptured aneurysm coiling and 4240 ruptured aneurysm clipping procedures. Declines were observed in aSAH admissions (−6.4% (95% CI −7.0% to −5.8%), p=0.0001) during the first year of the pandemic compared with the prior year, most pronounced in high-volume SAH and high-volume COVID-19 hospitals. There was a trend towards a decline in mild and moderate presentations of subarachnoid haemorrhage (SAH) (mild: −5% (95% CI −5.9% to –4.3%), p=0.06; moderate: −8.3% (95% CI −10.2% to –6.7%), p=0.06) but no difference in higher SAH severity. The ruptured aneurysm clipping rate remained unchanged (30.7% vs 31.2%, p=0.58), whereas ruptured aneurysm coiling increased (53.97% vs 56.5%, p=0.009). There was no difference in aSAH in-hospital mortality rate (19.1% vs 20.1%, p=0.12).ConclusionDuring the first year of the pandemic, there was a decrease in aSAH admissions volume, driven by a decrease in mild to moderate presentation of aSAH. There was an increase in the ruptured aneurysm coiling rate but neither change in the ruptured aneurysm clipping rate nor change in aSAH in-hospital mortality.Trial registration numberNCT04934020.

year	journal	country	edition	language
2022-10-01	Journal of neurology, neurosurgery, and psychiatry

10.1136/jnnp-2022-329200 https://pubmed.ncbi.nlm.nih.gov/35902229